control group:Valsartan/Amlodipine+Tengxian antihypertensive tablets placebo
Sponsors
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Conditions
Essential Hypertension
Phase 2
A multicenter randomized, double-blind, placebo-controlled trial for Teng-Fu Jiang-Ya tablets combined with Valsartan/Amlodipine in the Treatment of primary hypertension (grade 2) with liver yang hyperactivity syndrome
RecruitingChiCTR2000030611
Start: 2020-07-01Updated: 2021-03-15
A multicenter randomized, double-blind, placebo-controlled trial for Teng-Fu Jiang-Ya tablets combined with Valsartan/Amlodipine in the Treatment of primary hypertension (grade 2) with liver yang hyperactivity syndrome
RecruitingITMCTR2000003098
Start: 2020-07-01Updated: 2023-02-20